- Investing Ideas
- /
- South Korean Healthcare Undervalued based on future growth
South Korean Healthcare Undervalued based on future growth
Results
7
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
7 companies
Dentium
Market Cap: ₩502.8b
Manufactures and sells dental medical instrument worldwide.
A145720
₩57,800.00
7D
0.5%
1Y
-4.5%
T&L
Market Cap: ₩356.8b
Engages in the manufacture and sale of medical and polymer material products in South Korea.
A340570
₩45,200.00
7D
0.1%
1Y
-32.2%
InBodyLtd
Market Cap: ₩332.8b
Provides body composition analysis solutions worldwide.
A041830
₩28,500.00
7D
2.7%
1Y
20.8%
Suheung
Market Cap: ₩301.3b
Engages in produces and sells hard and soft capsules.
A008490
₩28,250.00
7D
9.3%
1Y
93.1%
Meta Biomed
Market Cap: ₩164.9b
Engages in the research, development, and production of dental and surgical materials in South Korea, Asia, Europe, the United States, and Africa.
A059210
₩6,190.00
7D
6.9%
1Y
55.5%
Vieworks
Market Cap: ₩162.1b
Develops, manufactures, and sells imaging systems and solutions.
A100120
₩18,500.00
7D
-1.0%
1Y
-20.4%
OSTEONIC
Market Cap: ₩136.4b
Osteonic Co., Ltd. develops, manufactures, and sells bone fixation systems.
A226400
₩6,840.00
7D
-2.8%
1Y
13.8%